Afuco™ Anti-RHD ADCC Therapeutic Antibody (Atorolimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to RhD. Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-149 |
Pricing | Inquiry |
Host | Human |
Target | RHD |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | ELISA, FC, IP, FuncS, IF, Neut |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |